Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Lung Cancer

Free Subscription 18.03.2019 2 Ann Surg Oncol 5 Anticancer Res 1 Arch Bronconeumol 9 BMC Cancer 1 Cancer Chemother Pharmacol 2 Cancer Lett 1 Cancer Res 2 Cancer Sci 3 Carcinogenesis 1 Clin Lung Cancer 4 Int J Cancer 2 Int J Oncol 1 J Cancer Res Clin Oncol 1 J Thorac Cardiovasc Surg 1 J Thorac Oncol 1 JAMA Oncol 2 Lancet Respir Med 1 Lung Cancer 2 N Engl J Med 1 Oncogene 3 Oncol Rep 1 Oncologist 1 PLoS Genet 3 PLoS One 1 Semin Oncol 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Surg Oncol

1. MEHTSUN WT, Chipidza FE, Fernandez-Del Castillo C, Hemingway K, et al
   Are Staging Computed Tomography (CT) Scans of the Chest Necessary in Pancreatic Adenocarcinoma?
   Ann Surg Oncol. 2018;25:3936-3942.
   PubMed     Text format     Abstract available
   
   
2. REN Y, Zhang L, Xie H, She Y, et al
   Lymph Node Micrometastasis Prognosticates Survival for Patients with Stage 1 Bronchogenic Adenocarcinoma.
   Ann Surg Oncol. 2018;25:3812-3819.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

3. HANSEN HC, Janssen S, Thieme C, Perlov A, et al
   Potential Impact of the Interval Between Imaging and Whole-brain Radiotherapy in Patients With Relatively Favorable Survival Prognoses.
   Anticancer Res. 2019;39:1343-1346.
   PubMed     Text format     Abstract available
   
   
4. ONISHI H, Yamasaki A, Nakamura K, Ichimiya S, et al
   Liprin-alpha4 as a New Therapeutic Target for SCLC as an Upstream Mediator of HIF1alpha.
   Anticancer Res. 2019;39:1179-1184.
   PubMed     Text format     Abstract available
   
   
5. REZNICZEK GA, Grunwald C, Hilal Z, Scheich J, et al
   ROBO1 Expression in Metastasizing Breast and Ovarian Cancer: SLIT2-induced Chemotaxis Requires Heparan Sulfates (Heparin).
   Anticancer Res. 2019;39:1267-1273.
   PubMed     Text format     Abstract available
   
   
6. CHO BC, DE Pas T, Kalofonos H, Wang Q, et al
   Prognostic Factors in Early-stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study.
   Anticancer Res. 2019;39:1403-1409.
   PubMed     Text format     Abstract available
   
   
7. YASUKAWA M, Ohbayashi C, Kawaguchi T, Kawai N, et al
   Analysis of Histological Grade in Resected Lung-invasive Adenocarcinoma.
   Anticancer Res. 2019;39:1491-1500.
   PubMed     Text format     Abstract available
   
   

   
   Arch Bronconeumol

8. FERNANDEZ TENA A, Guzman Taveras R
   Usefulness of Magnetic Resonance in Suspected Lung Cancer in Silicosis Patients.
   Arch Bronconeumol. 2019 Mar 9. pii: S0300-2896(19)30023.
   PubMed     Text format    
   
   

   
   BMC Cancer

9. ZHANG C, Mao M, Guo X, Cui P, et al
   Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer.
   BMC Cancer. 2019;19:238.
   PubMed     Text format     Abstract available
   
   
10. GUO Y, Wang X, Xiao J, Xu Y, et al
    Lung squamous cell carcinoma with solitary ocular metastasis and its successful treatment with thoracic surgery and chemotherapy: an interesting and rare case report.
    BMC Cancer. 2018;18:1004.
    PubMed     Text format     Abstract available
    
    
11. JIN B, Zhang S, Chuang X, Yu P, et al
    Breast cancer and synchronous multiple primary lung adenocarcinomas with heterogeneous mutations: a case report.
    BMC Cancer. 2018;18:1138.
    PubMed     Text format     Abstract available
    
    
12. YOSHIDA R, Sasaki T, Umekage Y, Tanno S, et al
    Highly sensitive detection of ALK resistance mutations in plasma using droplet digital PCR.
    BMC Cancer. 2018;18:1136.
    PubMed     Text format     Abstract available
    
    
13. RICH A, Baldwin D, Alfageme I, Beckett P, et al
    Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries.
    BMC Cancer. 2018;18:1144.
    PubMed     Text format     Abstract available
    
    
14. SCHWARTZ RM, Lieberman-Cribbin W, Wolf A, Flores RM, et al
    Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma.
    BMC Cancer. 2018;18:1188.
    PubMed     Text format     Abstract available
    
    
15. LU L, Liu Q, Wang P, Wu Y, et al
    MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway.
    BMC Cancer. 2019;19:209.
    PubMed     Text format     Abstract available
    
    
16. ESFANDI F, Taheri M, Omrani MD, Shadmehr MB, et al
    Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues.
    BMC Cancer. 2019;19:222.
    PubMed     Text format     Abstract available
    
    
17. WOOD R, Taylor-Stokes G
    Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage.
    BMC Cancer. 2019;19:214.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Chemother Pharmacol

18. KILICKAP S, Onder S, Dizdar O, Erman M, et al
    Short-time use of crizotinib as neoadjuvant in ALK-positive non-small cell lung carcinoma can be a chance for resectability.
    Cancer Chemother Pharmacol. 2019 Mar 12. pii: 10.1007/s00280-019-03810.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Lett

19. SHIMOMURA I, Yokoi A, Kohama I, Kumazaki M, et al
    Drug library screen reveals benzimidazole derivatives as selective cytotoxic agents for KRAS-mutant lung cancer.
    Cancer Lett. 2019;451:11-22.
    PubMed     Text format     Abstract available
    
    
20. CASAL-MOURINO A, Valdes L, Barros-Dios JM, Ruano-Ravina A, et al
    Lung cancer survival among never smokers.
    Cancer Lett. 2019 Mar 6. pii: S0304-3835(19)30133.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

21. ZOU T, Meyerson M
    Circulating Tumor DNA Provides a Sneak Peek into Treatment Responses in Non-Small Cell Lung Cancer.
    Cancer Res. 2019;79:1038-1040.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Sci

22. FURUTA M, Kikuchi H, Shoji T, Takashima Y, et al
    DLL3 regulates the migration and invasion of small cell lung cancer by modulating Snail.
    Cancer Sci. 2019 Mar 15. doi: 10.1111/cas.13997.
    PubMed     Text format     Abstract available
    
    
23. WANG L, Li X, Ren Y, Geng H, et al
    Cancer-associated fibroblasts contribute to cisplatin resistance via modulating ANXA3 in lung cancer cells.
    Cancer Sci. 2019 Mar 13. doi: 10.1111/cas.13998.
    PubMed     Text format     Abstract available
    
    

    
    Carcinogenesis

24. ELISIA I, Cho B, Hay M, Li MY, et al
    The Effect of Diet and Exercise on Tobacco Carcinogen-induced Lung Cancer.
    Carcinogenesis. 2019 Mar 15. pii: 5381155. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
25. MA B, Villalta PW, Hochalter JB, Stepanov I, et al
    Methyl DNA Phosphate Adduct Formation in Lung Tumor Tissue and Adjacent Normal Tissue of Lung Cancer Patients.
    Carcinogenesis. 2019 Mar 12. pii: 5374856. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
26. HOSGOOD HD, Hu W, Rothman N, Klugman M, et al
    Variation in Ribosomal DNA copy number is associated with lung cancer risk in a prospective cohort study.
    Carcinogenesis. 2019 Mar 12. pii: 5374822. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Clin Lung Cancer

27. FELD E, Singhi EK, Phillips S, Huang LC, et al
    Palliative Care Referrals for Advanced Non-small-cell Lung Cancer (NSCLC): Patient and Provider Attitudes and Practices.
    Clin Lung Cancer. 2019 Feb 20. pii: S1525-7304(19)30021.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

28. LUO J, Chimge NO, Zhou B, Flodby P, et al
    CLDN18.1 attenuates malignancy and related signaling pathways of lung adenocarcinoma in vivo and in vitro.
    Int J Cancer. 2018;143:3169-3180.
    PubMed     Text format     Abstract available
    
    
29. YANG CC, Chang CK, Chang MT, Shyur LF, et al
    Plant galactolipid dLGG suppresses lung metastasis of melanoma through deregulating TNF-alpha-mediated pulmonary vascular permeability and circulating oxylipin dynamics in mice.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31663.
    PubMed     Text format     Abstract available
    
    
30. BOYSEN AK, Spindler KL, Hoyer M, Mortensen FV, et al
    Metastasis directed therapy for liver and lung metastases from colorectal cancer - a population based study.
    Int J Cancer. 2018 Jun 19. doi: 10.1002/ijc.31626.
    PubMed     Text format     Abstract available
    
    
31. MARWITZ S, Heinbockel L, Scheufele S, Kugler C, et al
    Fountain of youth for squamous cell carcinomas? On the epigenetic age of non-small cell lung cancer and corresponding tumor-free lung tissues.
    Int J Cancer. 2018;143:3061-3070.
    PubMed     Text format     Abstract available
    
    

    
    Int J Oncol

32. OTHMAN N, Nagoor NH
    Overexpression of miR3615p plays an oncogenic role in human lung adenocarcinoma through the regulation of SMAD2.
    Int J Oncol. 2019;54:306-314.
    PubMed     Text format     Abstract available
    
    
33. WANG S, Gao P, Li N, Chen P, et al
    Autocrine secretions enhance radioresistance in an exosomeindependent manner in NSCLC cells.
    Int J Oncol. 2019;54:229-238.
    PubMed     Text format     Abstract available
    
    

    
    J Cancer Res Clin Oncol

34. FANG L, Wang L, Wang Y, Wu Y, et al
    Predictors and survival impact of station 4L metastasis in left non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2019 Mar 16. pii: 10.1007/s00432-019-02880.
    PubMed     Text format     Abstract available
    
    

    
    J Thorac Cardiovasc Surg

35. VAN BERKEL V
    Commentary: Still not enough data yet-Sublobar resection versus lobectomy for lung cancer.
    J Thorac Cardiovasc Surg. 2019 Feb 19. pii: S0022-5223(19)30461.
    PubMed     Text format    
    
    

    
    J Thorac Oncol

36. OSAROGIAGBON RU, Veronesi G, Fang W, Ekman S, et al
    Early Stage Non-Small Cell Lung Cancer: Advances in Thoracic Oncology 2018.
    J Thorac Oncol. 2019 Mar 6. pii: S1556-0864(19)30199.
    PubMed     Text format     Abstract available
    
    

    
    JAMA Oncol

37. SUN A, Hu C, Wong SJ, Gore E, et al
    Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial.
    JAMA Oncol. 2019 Mar 14. pii: 2728245. doi: 10.1001/jamaoncol.2018.7220.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Respir Med

38. DINGEMANS AM, Hendriks L
    Immune checkpoint inhibitors in non-small-cell lung cancer: key to long-term survival?
    Lancet Respir Med. 2019 Mar 12. pii: S2213-2600(19)30043.
    PubMed     Text format    
    
    
39. LEIGHL NB, Hellmann MD, Hui R, Carcereny E, et al
    Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study.
    Lancet Respir Med. 2019 Mar 12. pii: S2213-2600(18)30500.
    PubMed     Text format     Abstract available
    
    

    
    Lung Cancer

40. ONO A, Isaka M, Serizawa M, Omae K, et al
    Corrigendum to "Genetic alterations of driver genes as independent prognostic factors for disease-free survival in patients with resected non-small cell lung cancer" [Lung Cancer 128 (2019) 152-157].
    Lung Cancer. 2019 Mar 12. pii: S0169-5002(19)30350.
    PubMed     Text format    
    
    

    
    N Engl J Med

41. ANTONIA SJ
    Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. Reply.
    N Engl J Med. 2019;380:990.
    PubMed     Text format    
    
    
42. KIM YH
    Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
    N Engl J Med. 2019;380:989-990.
    PubMed     Text format    
    
    

    
    Oncogene

43. HAMAIDI I, Coquard C, Danilin S, Dormoy V, et al
    The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma.
    Oncogene. 2019;38:60-72.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

44. JIN HO, Hong SE, Kim JY, Kim MR, et al
    Induction of HSP27 and HSP70 by constitutive overexpression of Redd1 confers resistance of lung cancer cells to ionizing radiation.
    Oncol Rep. 2019 Feb 28. doi: 10.3892/or.2019.7036.
    PubMed     Text format     Abstract available
    
    
45. TENG X, Fan XF, Li Q, Liu S, et al
    XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
    Oncol Rep. 2019;41:1875-1882.
    PubMed     Text format     Abstract available
    
    
46. JING J, Liu J, Wang Y, Zhang M, et al
    The role of ZBTB38 in promoting migration and invasive growth of bladder cancer cells.
    Oncol Rep. 2018 Dec 18. doi: 10.3892/or.2018.6937.
    PubMed     Text format     Abstract available
    
    

    
    Oncologist

47. CHAE YK, Davis AA, Agte S, Pan A, et al
    Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer.
    Oncologist. 2019 Mar 13. pii: theoncologist.2018-0433.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Genet

48. SUN G, Ding X, Bi N, Wang Z, et al
    Molecular predictors of brain metastasis-related microRNAs in lung adenocarcinoma.
    PLoS Genet. 2019;15:e1007888.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

49. CHOI YJ, Park GM, Rho JK, Kim SY, et al
    Correction: Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors.
    PLoS One. 2019;14:e0213984.
    PubMed     Text format     Abstract available
    
    
50. 
    Expression of Concern: Autophagosome-Mediated EGFR Down-Regulation Induced by the CK2 Inhibitor Enhances the Efficacy of EGFR-TKI on EGFR-Mutant Lung Cancer Cells with Resistance by T790M.
    PLoS One. 2019;14:e0213989.
    PubMed     Text format    
    
    
51. OTSUKA M, Monzen H, Matsumoto K, Tamura M, et al
    Evaluation of lung toxicity risk with computed tomography ventilation image for thoracic cancer patients.
    PLoS One. 2018;13:e0204721.
    PubMed     Text format     Abstract available
    
    

    
    Semin Oncol

52. LAKING G, Evans J, Metcalfe S, Strother RM, et al
    Response to Cameron et al "Mind the graph" Semin Oncol. 2018.
    Semin Oncol. 2018;45.
    PubMed     Text format    
    
    

    
    Thorax

53. RAGHU VK, Zhao W, Pu J, Leader JK, et al
    Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models.
    Thorax. 2019 Mar 12. pii: thoraxjnl-2018-212638.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: